Skip to content

Add your earlier progress to your account?

From before you signed in, this browser has:

Which plan do you want to keep?

You answered the plan questions before signing in. These answers differ from the plan saved on your account.

SettingSaved planNew answers

Study progress is waiting to be saved

Gram-Negative and Fastidious Bloodstream Isolates

About 23 min · 13 sections · 3 self-checks

On this page

Gram-negative organisms in blood fall into three laboratory groups, and each group needs a different workup. Most gram-negative pathogens, including the fastidious HACEK group (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella), grow in a continuous-monitoring blood culture within the standard incubation period of about 5 days on a validated routine protocol, so the laboratory's task is identification and correct susceptibility reporting.1 Brucella is the exception in this group. Recovery is delayed and peaks at 3 to 4 days. Most other bloodstream pathogens are detected at 6 to 36 hours. Suspected brucellosis therefore requires the modified incubation plan described below.2 A second, smaller group concentrates in the reticuloendothelial system (the macrophage-rich tissues of marrow, liver, and spleen), and bone marrow culture can recover these organisms when peripheral blood cultures are negative. A third group of vector-borne and zoonotic bacteria circulates in blood but grows poorly or not at all in routine bottles, so the diagnostic specimen is blood, buffy coat, or serum tested by serology, stained smear, or nucleic acid amplification.

Blood-culture collection, bottle monitoring, and the positive-bottle workup are covered in Blood Cultures and Gram-Positive Blood Isolates. General transport, direct stains, media, incubation, and staged reporting are covered in Specimen Collection, Transport, and Primary Processing in Microbiology. This lesson starts at a positive bottle with gram-negative cocci or bacilli on the Gram stain, or at a clinical picture that suggests an organism routine bottles rarely recover.

Gram-negative cocci: Neisseria

Characteristics. Neisseria species are nonmotile, catalase- and oxidase-positive gram-negative cocci, typically paired with flattened adjacent sides that give a kidney-bean or coffee-bean appearance. Young cultures may also show tetrads. Many strains require blood, serum, cholesterol, or oleic acid supplementation to counteract inhibitory fatty acids in the medium, and N. gonorrhoeae and N. meningitidis generally require added CO2 for primary isolation, a requirement that varies by strain and often fades on subculture.3

Clinical significance. N. meningitidis colonizes the upper respiratory mucosa. Most carriers develop group-specific bactericidal antibody within 7 to 10 days and remain well. A minority progress to meningococcemia and meningitis, sometimes with pleuritis, pericarditis, or arthritis. The organism's lipopolysaccharide endotoxin activates the clotting cascade, and the resulting microvascular fibrin deposition, hemorrhage, and shock produce the petechial-to-ecchymotic rash of meningococcemia. A blood or cerebrospinal-fluid recovery of N. meningitidis is a critical result. Call it under your laboratory's urgent-notification procedure.3

N. gonorrhoeae is considered pathogenic in every specimen, with or without symptoms. Urethral infection in men is usually symptomatic. Endocervical infection in women is commonly asymptomatic until ascending infection has produced pelvic inflammatory disease, with tubal scarring that predisposes to infertility or ectopic pregnancy.3 Antigenically variable type IV pili mediate adherence and are a principal gonococcal virulence factor.3 Genital-tract collection and the combined gonorrhea and chlamydia molecular workflow are taught with genital-tract bacteriology.

Specimen handling and media. Pathogenic Neisseria are damaged by drying, temperature extremes, and delay, so inoculate material directly to warmed media whenever possible and incubate it promptly at 35 to 36.5 °C in about 5% CO2, supplied by a CO2 incubator, a candle-extinction jar, or a CO2-generating tablet system. Incubate media bound for a reference laboratory overnight first, so growth is established before transport.4 Selective chocolate-based media for N. gonorrhoeae combine an inhibitor of gram-positive organisms (vancomycin in modified Thayer-Martin and Martin-Lewis media, lincomycin in some New York City-type formulations), colistin against other gram-negative organisms, an antifungal agent (nystatin, anisomycin, or amphotericin B), and trimethoprim to suppress swarming Proteus. Some gonococcal strains are inhibited by the vancomycin in selective media, so inoculate a nonselective chocolate agar plate in parallel when the specimen comes from a sterile site or recovery is critical.4

Identification. A typical colony on selective medium with a positive oxidase reaction and gram-negative diplococci on smear supports a presumptive identification of N. gonorrhoeae, which the laboratory can report as a preliminary result. Confirmatory testing by a method with a different principle is required before the isolate is reported as N. gonorrhoeae, because other Neisseria species grow on the same media. In suspected sexual assault or abuse, the isolate must be confirmed by two tests of different principles and preserved for possible retesting.4

Classic confirmation uses acid production from carbohydrates in cystine trypticase agar (CTA) base medium (glucose, maltose, lactose, sucrose, and fructose, with a carbohydrate-free control), read at 24-hour intervals for up to 72 hours. Commercial enzyme-substrate and rapid carbohydrate-utilization kits give the same identifications in 1 to 4 hours.3

Species Growth on selective GC medium Oxidase Acid from glucose Acid from maltose Acid from lactose
N. gonorrhoeae Most strains + + − −
N. meningitidis + + + + −
N. cinerea Some strains + − (weak reactions occur) − −
N. lactamica + + + + +
Moraxella catarrhalis Variable + − − −

Misreading color changes is a common error and can lead to N. meningitidis, N. cinerea, or Kingella denitrificans being reported as N. gonorrhoeae.4 An occasional N. meningitidis isolate gives aberrant glucose-negative, maltose-negative, or fully asaccharolytic results. When meningococcus is still suspected, slide agglutination with grouping antisera resolves the identification. Moraxella catarrhalis is separated from the asaccharolytic neisseriae by its positive DNase and butyrate esterase reactions.3

For urogenital specimens, nucleic acid amplification testing (NAAT) has largely replaced culture because it is more sensitive and does not require viable organisms.4,5

Resistance notes. Circulating US gonococci are inadequately susceptible to penicillin and tetracycline, so those drugs are never assumed active. When symptoms persist after treatment, culture and antimicrobial susceptibility testing are indicated. A pharyngeal gonorrhea test of cure is collected 7 to 14 days after treatment, for culture or NAAT. Test any positive test-of-cure culture for susceptibility. A chromogenic cephalosporin (nitrocefin) test detects β-lactamase production and is used for surveillance and isolate characterization. It no longer guides therapy. Susceptibility methods and interpretive criteria are covered in antimicrobial susceptibility testing.5

Gram-negative nonfermenting bacilli

Nonfermenters are gram-negative bacilli that fail to ferment glucose or other carbohydrates, using oxidative pathways or none at all. They account for roughly 15% of gram-negative bacilli recovered in clinical laboratories and live in soil, water, and moist hospital environments, appearing on patients mainly as health-care-associated colonizers. Pseudomonas aeruginosa is the most frequently recovered clinically significant nonfermenter. Most of the remainder are Acinetobacter species, Stenotrophomonas maltophilia, and the Burkholderia cepacia complex.3

Pseudomonas aeruginosa. An aerobic, catalase- and oxidase-positive gram-negative bacillus with oxidative metabolism, motile by polar flagella. It thrives in nearly any moist reservoir, including medical equipment, disinfectant solutions, and soaps, and colonization increases with length of hospitalization. Serious infection follows burns, surgical wounds, urinary instrumentation, hematologic and immunologic disease, cystic fibrosis, and mechanical ventilation. Its virulence factors include a slime polysaccharide, endotoxin, complement-inactivating proteases, and exotoxin A, which ADP-ribosylates elongation factor 2, shutting down host protein synthesis and producing local tissue necrosis.3

Presumptive recognition is based on a grape-like or corn-tortilla odor, rough or ground-glass colonies on blood agar, and pigment: blue-green pyocyanin, yellow-green fluorescent pyoverdin, or both, often with a metallic colony sheen. A positive oxidase reaction, growth at 42 °C, and an alkaline slant with no change in the butt on triple sugar iron agar complete the presumptive identification.3 Clinically significant isolates receive susceptibility testing. P. aeruginosa is intrinsically resistant to amoxicillin-clavulanate, ceftriaxone, trimethoprim-sulfamethoxazole, the tetracyclines, ertapenem, and tigecycline, so suppress an apparently susceptible result for one of these agents under the intrinsic-resistance rules of your laboratory's adopted Clinical and Laboratory Standards Institute (CLSI) M100 edition.6

Acinetobacter. Short rod-shaped to coccoid, nonmotile, oxidase-negative, strictly aerobic organisms that decolorize poorly on Gram stain and can be mistaken for gram-positive cocci. They inhabit soil and water and occasionally healthy skin, and they cause health-care-associated bacteremia, pneumonia, bacteriuria, and wound infection. A negative oxidase reaction, nonmotility, and failure to reduce nitrate separate the genus from Pseudomonas. Purplish colonies on MacConkey agar from crystal violet uptake, without lactose fermentation, are characteristic.3 Carbapenem-resistant A. baumannii (CRAB) is a major treatment problem. Current Infectious Diseases Society of America (IDSA) treatment guidance depends on the species and the carbapenem result, so accurate species-level identification and carbapenem results directly affect treatment.7

Burkholderia cepacia complex. Aerobic, non-spore-forming, catalase-positive gram-negative rods, motile by polar flagella. B. pseudomallei and nonmotile B. mallei form the separate B. pseudomallei complex. Both are Tier 1 select agents, and an isolate suggesting either is handled under the rules in Sentinel Recognition and Referral of Select Agents and is never worked up as a routine nonfermenter. The complex, at least 20 closely related species, is an important health-care-associated pathogen in cystic fibrosis and chronic granulomatous disease, where chronic infection accelerates decline. Complex members are phenotypically nearly indistinguishable from one another and from B. gladioli, Ralstonia, Cupriavidus, and Pandoraea, so species-level confirmation is molecular or by validated mass spectrometry.3 Isolates of the complex are characteristically resistant to the aminoglycosides and the polymyxins. Most Burkholderia carry a modified lipopolysaccharide that confers intrinsic polymyxin resistance, and a restrictive outer membrane limits aminoglycoside entry. CLSI no longer lists intrinsic-resistance entries for the complex, because the previous entries were found unreliable. Disk diffusion breakpoints were removed in 2024 and minimum inhibitory concentration (MIC) breakpoints in 2025, so the current M100 publishes no breakpoints for the complex and recommends against routine susceptibility testing. When testing is performed on request, frozen reference broth microdilution is the only method CLSI calls reproducible for the complex. Report the result with the caution that correlation of MIC values with clinical outcome is not known.6,23,24

Stenotrophomonas maltophilia. An opportunistic health-care-associated pathogen favored by mechanical ventilation, broad-spectrum antibiotic exposure, catheters, and neutropenia, and a respiratory colonizer in cystic fibrosis. Recovery alone does not establish infection. Distinguishing bench features are a negative oxidase reaction paired with positive DNase activity, lavender-green colonies with an ammonia-like odor on blood and MacConkey agar, motility, and oxidative utilization of glucose and maltose.3 The organism is intrinsically resistant to the carbapenems, so carbapenem therapy aimed at a presumed Pseudomonas or Acinetobacter infection leaves S. maltophilia untreated. Current IDSA guidance treats ceftazidime as inactive regardless of the in vitro result, so follow the laboratory's reporting rules for this organism.6,7

Feature P. aeruginosa Acinetobacter baumannii B. cepacia complex S. maltophilia
Oxidase + − + −
Motility + − + +
Growth at 42 °C + + Variable Variable
Pigment Blue-green pyocyanin, yellow-green fluorescent pyoverdin, or both None None None
DNase − Variable − +
Carbapenems Antipseudomonal carbapenems (imipenem, meropenem) usually active; must be tested. Ertapenem is intrinsically inactive and is never reported Resistance common (CRAB) No current CLSI breakpoints; AST not performed routinely Intrinsically resistant

Less commonly encountered nonfermenters, among them Alcaligenes, Achromobacter, Chryseobacterium, Brevundimonas, Comamonas, and Ralstonia, are usually colonizers or contaminants. Repeated recovery from a sterile site, or recovery from an immunosuppressed patient with an indwelling device, indicates that such an isolate is clinically significant.3

HACEK organisms and Haemophilus identification

The HACEK acronym groups fastidious, slow-growing gram-negative organisms that share oral and upper-respiratory carriage and a predilection for subacute bacterial endocarditis: Haemophilus species (particularly H. parainfluenzae), Aggregatibacter species (including A. aphrophilus, formerly Haemophilus aphrophilus, and A. actinomycetemcomitans, formerly Actinobacillus actinomycetemcomitans), Cardiobacterium hominis, Eikenella corrodens, and Kingella species. Historically these organisms were considered hard to recover, and laboratories extended incubation for suspected HACEK endocarditis. With current continuous-monitoring systems that practice is obsolete. HACEK organisms are reliably detected within the standard 5-day incubation, and extended incubation with terminal blind subculture does not improve recovery. Species-level identification, usually by mass spectrometry, can take several days after the bottle signals.1

Haemophilus growth factors. Haemophilus species are oxidase-positive, facultatively anaerobic, small pleomorphic gram-negative rods or coccobacilli defined at the bench by their requirements for X factor (hemin) and V factor (nicotinamide adenine dinucleotide, NAD). Chocolate agar supplies both factors from heat-lysed blood. On media lacking free NAD, a streak of Staphylococcus aureus releases it, and dependent colonies satellite around the streak. The porphyrin test identifies X-factor-independent species directly. These species convert δ-aminolevulinic acid to porphobilinogen and porphyrins, detected as a red color with Kovac's reagent or red fluorescence under a Wood's lamp. X-dependent species cannot make this conversion.3

Species Porphyrin X factor required V factor required Sucrose fermentation Hemolysis Catalase
H. influenzae − + + − − +
H. haemolyticus − + + − + +
H. parahaemolyticus + − + + + Variable
H. ducreyi − + − − − −
H. parainfluenzae + − + + − Variable

Haemophilus influenzae. The polysaccharide capsule, in six serotypes designated a through f, is a major virulence factor in invasive disease. Conjugate vaccination sharply reduced invasive type b disease, and acapsular nontypeable strains are now the most frequent cause of invasive H. influenzae infection in the United States as well as the dominant cause of otitis media and exacerbations of chronic bronchitis.8 H. parainfluenzae is usually a pharyngeal commensal but occasionally produces similar illness and endocarditis.3

CLSI recommends testing blood and cerebrospinal-fluid isolates of H. influenzae against ampicillin, a third-generation cephalosporin, chloramphenicol, and meropenem.6 About 28% of invasive US isolates are ampicillin-resistant, nearly always through a TEM-1 or ROB-1 β-lactamase detectable with a nitrocefin screen.9 The screen does not detect β-lactamase-negative, ampicillin-resistant (BLNAR) strains, which have altered penicillin-binding proteins. A negative β-lactamase screen therefore cannot establish susceptibility to ampicillin, amoxicillin-clavulanate, or cefuroxime. Laboratories consider local BLNAR rates when deciding whether full susceptibility testing must accompany the screen. β-Lactamase-producing strains remain susceptible to ceftriaxone and cefotaxime, and ceftriaxone and levofloxacin susceptibility has remained nearly universal in recent US series.10

Other HACEK members. Aggregatibacter aphrophilus overlaps phenotypically with H. parainfluenzae and the other HACEK species, so species identification requires mass spectrometry or molecular methods. Eikenella corrodens, an oral commensal, appears in endocarditis and also in abscesses, cellulitis, and human-bite wound infections, usually as part of a mixed flora. Cardiobacterium hominis and Kingella species share the same oral carriage and endocarditis association.3

H. ducreyi, included here for its genus, causes chancroid, a genital ulcer disease. Its Gram stain shows gram-negative bacilli in parallel rows and clusters, the school-of-fish arrangement, and culture requires heavily enriched vancomycin-containing media incubated at about 33 °C in a humid, CO2-enriched atmosphere. The chancroid workup is covered in genital-tract bacteriology.3

Bone marrow culture

Bone marrow culture is requested when an intracellular or reticuloendothelial-system pathogen is suspected and peripheral blood cultures have been unrevealing, classically for Brucella species and Salmonella enterica serotype Typhi. Both organisms concentrate in reticuloendothelial tissue, including marrow, so marrow culture can remain positive in chronic or relapsing disease and after antimicrobial exposure has suppressed peripheral bacteremia. In typhoid fever, marrow culture remains positive more often than blood culture once therapy has begun.11 A marrow specimen for suspected brucellosis is inoculated into a blood-culture bottle or another validated system and incubated under the plan for suspected brucellosis. Because recovery of Brucella is often delayed compared with other bloodstream pathogens, current American Society for Microbiology (ASM) and Association of Public Health Laboratories (APHL) sentinel-laboratory guidance directs extending blood-culture bottle incubation from the routine 5 days to about 10 days, with a blind or terminal subculture considered at 7 or 10 days when brucellosis remains suspected after negative bottles. Brucella is a biosafety level 3 (BSL-3), laboratory-acquired-infection risk organism. The laboratory must be told of suspected brucellosis in advance so that the isolate is handled under biological safety cabinet containment and referred through the public-health sentinel-laboratory procedure.2 Identification and containment of Brucella and Salmonella Typhi are covered in enteric and select-agent bacteriology.

Vector-borne and zoonotic agents diagnosed from blood or serum

A group of spirochetal, rickettsial, and related intracellular bacteria produce systemic bloodstream illness after an arthropod bite or animal contact, and routine blood-culture bottles recover them poorly or not at all. For these agents, the laboratory's role is to select the right specimen and test (serology, stained blood smear, or nucleic acid amplification) and to interpret the result in relation to the timing of the illness. Serologic method mechanics are covered in Immunology. This section covers organism-level test selection and interpretation.

Lyme borreliosis

Borrelia burgdorferi sensu stricto and, rarely, B. mayonii cause Lyme disease in the United States, the latter in the upper Midwest. B. garinii and B. afzelii are Eurasian genospecies. Ixodes hard ticks transmit the spirochete, and in most cases the tick must be attached for more than 24 hours before transmission occurs.12

Laboratory diagnosis is based on serology, because spirochete numbers in blood and cerebrospinal fluid are too low for reliable culture or amplification. The two-tiered algorithm of the Centers for Disease Control and Prevention (CDC) begins with a sensitive first-tier enzyme immunoassay. A positive or equivocal result reflexes to a second tier, either an IgM and IgG immunoblot or, in modified two-tiered testing cleared by the Food and Drug Administration (FDA) in 2019, a second, different enzyme immunoassay.13,14 Band-count criteria apply only to immunoblots: an IgG blot is positive with 5 of 10 defined bands, an IgM blot with 2 of 3.15 Disregard a positive IgM result when the illness has lasted more than 30 days, because by then a true infection has produced IgG. Serology may be falsely negative during the first 4 to 6 weeks of infection, so CDC does not recommend serologic testing when a patient with a plausible exposure has erythema migrans, which is diagnosed clinically. Titers stay elevated long after cure, so serology is not used to monitor treatment response. An antibody index comparing cerebrospinal fluid with serum supports neuroborreliosis, and nucleic acid amplification performs best on synovial fluid in Lyme arthritis, where organism burden is highest.13

Southern tick-associated rash illness (STARI) follows a lone star tick bite with an erythema migrans-like rash. Its cause is unknown, Lyme serology is negative, and no diagnostic laboratory test exists.16

Relapsing fever

Louse-borne relapsing fever (B. recurrentis, transmitted by the human body louse from a purely human reservoir) and soft tick relapsing fever (several Borrelia species transmitted by Ornithodoros soft ticks) produce cycles of recurring fever as the spirochete varies its surface antigens, escapes the antibody response, and re-emerges. Spirochetemia peaks during fever, so peripheral blood collected during a febrile episode is the classic specimen. Spirochetes are found by darkfield examination or on a stained smear, with Wright-Giemsa, acridine orange, or fluorescent antibody staining. Polymerase chain reaction (PCR) on whole blood is more sensitive than microscopy and can stay positive between febrile episodes and early in treatment. Many assays cannot separate the relapsing-fever species from one another. Serology is most informative 14 days or more after onset. Antigenic variability and cross-reactivity with the Lyme borreliae limit its usefulness. Assays using the GlpQ antigen, which the Lyme group lacks, are more specific for relapsing fever.17

Leptospirosis

Leptospira species are tightly coiled spirochetes with hooked ends that give a question-mark shape. Rodents are the principal reservoir, shedding organisms in urine, and infection follows contact with contaminated water or soil. Illness is classically biphasic, a bacteremic phase followed by an immune phase as antibody appears. During the first week of illness, real-time PCR on whole blood provides the early confirmed diagnosis. After the first week, urine becomes the better PCR specimen. The microscopic agglutination test (MAT), performed with live antigen in reference laboratories, is the serologic reference method. Agglutinating antibody appears toward the end of the first week, peaks at 3 to 4 weeks, and can persist for years. Culture is insensitive and slow and is never used as the sole method. Incubate Fletcher or Ellinghausen-McCullough-Johnson-Harris (EMJH) medium at 28 to 30 °C in the dark and examine it weekly by darkfield microscopy, for up to about 13 weeks, for spinning hooked organisms growing below the surface.18

Rickettsioses and scrub typhus

Rickettsia species are small, obligately intracellular gram-negative bacilli that escape the phagosome with their own phospholipase and replicate free in the cytosol. Spotted-fever-group organisms also use host-cell actin to move from cell to cell. They spread through vascular endothelium and produce vasculitis. Typhus-group organisms accumulate inside the cell until it ruptures. Orientia tsutsugamushi, the agent of scrub typhus, is a related but distinct genus.3

Group Agent Disease Vector Laboratory notes
Spotted fever R. rickettsii Rocky Mountain spotted fever Dermacentor variabilis (East, Central, Pacific coast), D. andersoni (West), Rhipicephalus sanguineus (Arizona, US-Mexico border) Endothelial invasion produces the underlying vasculitis
Spotted fever R. conorii Boutonneuse (Mediterranean spotted) fever Rhipicephalus sanguineus Travel-associated in US patients
Spotted fever R. akari Rickettsialpox House mouse mite Eschar at the mite-bite site
Spotted fever R. felis Flea-borne spotted fever Cat flea Diagnosed almost exclusively by NAAT; no confirmed human isolates
Typhus R. prowazekii Epidemic louse-borne typhus; Brill-Zinsser disease on recrudescence Human body louse feces A US Department of Health and Human Services (HHS) select agent
Typhus R. typhi Murine (endemic) typhus Flea feces, rat reservoir Southern US foci
Scrub typhus Orientia tsutsugamushi Scrub typhus Chigger (larval mite) bite Eschar common at the chigger-bite site; its absence does not exclude the disease

Treatment across the group is empiric, because laboratory confirmation is retrospective. The indirect immunofluorescence assay (IFA) is the serologic reference standard and is insensitive during the first week of illness, when most patients present. Confirmation requires a fourfold or greater rise in IgG titer between an acute specimen and a convalescent specimen collected 2 to 4 weeks later. A single elevated titer never confirms acute infection, since 5% to 10% of healthy people have reciprocal R. rickettsii IgG titers of 64 or more. PCR of blood or buffy coat can detect infection earlier. Its sensitivity is limited by low circulating organism numbers and reduced by prior doxycycline. PCR performs better on eschar swabs and biopsy tissue. Scrub typhus diagnosis combines IFA serology with PCR, since a single test is rarely definitive.19

Rickettsia prowazekii is an HHS select agent. When it is identified or credibly suspected, follow your laboratory's select-agent referral procedure.20

Ehrlichiosis and anaplasmosis

Ehrlichia and Anaplasma are small, tick-borne, obligately intracellular gram-negative coccobacilli that infect leukocytes and grow as intracytoplasmic clusters, morulae, visible on a Wright-Giemsa-stained smear.19

Agent Disease Target cell Vector
Ehrlichia chaffeensis Human monocytic ehrlichiosis Monocytes Amblyomma americanum (lone star tick)
Ehrlichia ewingii Ehrlichiosis ewingii Neutrophils A. americanum
Anaplasma phagocytophilum Human granulocytic anaplasmosis Neutrophils Ixodes species

Careful smear review for morulae, ideally on a buffy-coat preparation, is the fastest presumptive test. Accompanying leukopenia and thrombocytopenia support the diagnosis. The smear is far more often positive in anaplasmosis than in E. chaffeensis ehrlichiosis. A negative smear does not exclude either infection. The infected cell type gives only a presumptive indication of the agent. Toxic granulation, Döhle bodies, and platelets overlying a leukocyte can be mistaken for morulae. PCR of whole blood is the most sensitive routine method. It performs best in the first week, and sensitivity falls within about 48 hours of doxycycline. IFA serology confirms retrospectively through a fourfold rise between paired specimens. IgM alone is unreliable, and antibody is commonly absent during the acute illness, so serology is not useful for acute diagnosis.19

Q fever

Coxiella burnetii is classified in the order Legionellales, near Legionella, and resembles the rickettsiae only clinically. It forms a spore-like small-cell variant highly resistant to heat, desiccation, and disinfectants. The organism persists in the environment and is transmitted by inhaled aerosols from birth products, dust, and animal products of infected livestock, and its infectious dose is very low. It is an HHS select agent and a CDC category B bioterrorism agent.20-21

Acute Q fever is usually a self-limited febrile illness. Chronic (persistent focalized) Q fever most often presents as C. burnetii endocarditis, usually on a previously damaged or prosthetic valve, or as vascular infection of an aneurysm or graft. Osteoarticular and other persistent foci also occur. A diagnosis of chronic Q fever requires an identified focus together with serology. Laboratory diagnosis is serologic and is based on the organism's two antigenic phases. Antibody against phase II antigen rises first and predominates in acute infection. Sustained high-titer antibody against phase I antigen indicates chronic infection. An anti-phase I IgG titer of 1:1024 or greater by IFA, with definite endocarditis or vascular infection, defines proven chronic Q fever. A phase I IgG titer of 1:800 or greater is a major criterion in the modified Duke endocarditis criteria. PCR of blood or serum is more sensitive than serology during the first 1 to 2 weeks of acute illness, before seroconversion.1,22

Bartonella infections

Bartonella species are fastidious, blood- and endothelium-tropic gram-negative bacteria transmitted by arthropod vectors from animal reservoirs. Primary isolation needs blood-enriched media and 5% CO2 and takes 5 days to several weeks, so culture is rarely diagnostic.3

Species Disease Vector or reservoir
B. henselae Cat scratch disease; bacillary angiomatosis and peliosis in immunocompromised hosts Cat scratch or bite; cat flea
B. quintana Trench fever; endocarditis; bacillary angiomatosis Human body louse feces
B. bacilliformis Oroya fever (acute hemolytic phase); verruga peruana (chronic cutaneous phase) Lutzomyia sandfly bite
B. elizabethae, B. vinsonii Infective endocarditis Various

IFA serology is the standard first test. Titers are low early in acute infection, so paired acute and convalescent specimens are often needed. Antibody cross-reacts between B. henselae and B. quintana and with Coxiella and Chlamydia species. PCR is far more sensitive on excised cardiac-valve tissue than on blood or serum in endocarditis. In the acute erythrocytic phase of Oroya fever, a Giemsa-stained blood smear shows red-violet organisms associated with red cells.1,3 At the bench, match the suspected agent to the specimen and the phase of illness before you choose a test, because for these organisms a specimen collected at the wrong time can give a false-negative result.

Practice

Check yourself 1 of 3

An oxidase-positive colony of gram-negative diplococci grows on selective GC medium from a genital specimen. What is required before the isolate is reported as Neisseria gonorrhoeae?

Correct. Colony, oxidase, and Gram stain give only a presumptive identification, because other Neisseria species grow on the same media. Confirmation by a different principle, such as carbohydrate utilization or an enzyme-substrate kit, precedes the report. In suspected sexual assault or abuse, two tests of different principles are required and the isolate is preserved.

Incorrect. Growth on chocolate agar repeats the colony features already seen. N. meningitidis, N. lactamica, and some N. cinerea also grow on selective GC medium, so a method with a different principle confirms the species.

Incorrect. Nitrocefin detects β-lactamase for surveillance and isolate characterization and gives no information about the species.

Review this section

Check yourself 2 of 3

A blood isolate of Haemophilus influenzae is β-lactamase-negative by nitrocefin. What does this mean for ampicillin?

Incorrect. BLNAR strains test nitrocefin negative and ampicillin resistant, and CLSI recommends ampicillin testing for blood and CSF isolates, so the test is still performed.

Incorrect. TEM-1 and ROB-1 are what a positive nitrocefin screen detects. This screen is negative, so any ampicillin resistance would come from altered penicillin-binding proteins.

Correct. β-Lactamase-negative, ampicillin-resistant (BLNAR) strains resist through altered penicillin-binding proteins that nitrocefin cannot detect. CLSI recommends ampicillin testing for blood and CSF isolates of H. influenzae, so this blood isolate still receives full susceptibility testing.

Review this section

Check yourself 3 of 3

A single acute-phase serum gives a reciprocal Rickettsia rickettsii IgG titer of 64 by IFA. How is this result interpreted?

Incorrect. Between 5% and 10% of healthy people have reciprocal R. rickettsii IgG titers of 64 or more, so one titer cannot confirm acute infection.

Incorrect. IgG by indirect immunofluorescence is the serologic reference for acute rickettsial infection. A single titer cannot place the infection in time. A fourfold rise between paired specimens shows current infection.

Correct. A single elevated titer does not confirm acute infection. The indirect immunofluorescence assay (IFA) is the serologic reference standard but is insensitive in the first week, so confirmation is retrospective and requires a fourfold or greater IgG rise between paired acute and convalescent specimens.

Review this section

References
  1. Liesman RM, Pritt BS, Maleszewski JJ, Patel R. Laboratory diagnosis of infective endocarditis. J Clin Microbiol. 2017;55(9):2599-2608. doi:10.1128/JCM.00635-17 Back to text
  2. American Society for Microbiology and Association of Public Health Laboratories. Brucellosis-causing Brucella species (BBS): Sentinel level clinical laboratory guidelines for suspected agents of bioterrorism and emerging infectious diseases. ASM; 2025. Accessed August 30, 2026. https://asm.org/guideline/brucellosis-causing-brucella-species-bbs-sentinel Back to text
  3. Carroll KC, Pfaller MA, Landry ML, McAdam AJ, Karlowsky JA, Patel R, Pritt BS, eds. Manual of Clinical Microbiology. 13th ed. ASM Press; 2023. Back to text
  4. Papp JR, Schachter J, Gaydos CA, Van Der Pol B. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014. MMWR Recomm Rep. 2014;63(RR-2):1-19. Accessed August 29, 2026. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6302a1.htm Back to text
  5. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(RR-4):1-187. doi:10.15585/mmwr.rr7004a1 Back to text
  6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 36th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2026. Accessed August 29, 2026. https://clsi.org/shop/standards/m100/ Back to text
  7. Tamma PD, Bonomo RA, Heil EL, Justo JA, Satlin MJ, Mathers AJ. IDSA 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Infectious Diseases Society of America; 2026. Accessed August 29, 2026. https://www.idsociety.org/practice-guideline/amr-guidance/ Back to text
  8. Oliver SE, Rubis AB, Soeters HM, et al. Epidemiology of invasive nontypeable Haemophilus influenzae disease—United States, 2008-2019. Clin Infect Dis. 2023;76(11):1889-1895. doi:10.1093/cid/ciad054 Back to text
  9. Potts CC, Rodriguez-Rivera LD, Retchless AC, et al. Antimicrobial susceptibility survey of invasive Haemophilus influenzae in the United States in 2016. Microbiol Spectr. 2022;10(3):e0257921. doi:10.1128/spectrum.02579-21 Back to text
  10. Morton AB, Vareechon C, Pettengill MA. Is beta-lactamase testing acceptably accurate for predicting Haemophilus influenzae susceptibility to beta-lactams? Epidemiological data from Philadelphia, USA, 2017-2023. Microbiol Spectr. 2023;11(5):e0129223. doi:10.1128/spectrum.01292-23 Back to text
  11. Centers for Disease Control and Prevention. Clinical guidance for typhoid fever. Accessed August 29, 2026. https://www.cdc.gov/typhoid-fever/hcp/clinical-guidance/index.html Back to text
  12. Centers for Disease Control and Prevention. How Lyme disease spreads. Accessed August 29, 2026. https://www.cdc.gov/lyme/causes/index.html Back to text
  13. Centers for Disease Control and Prevention. Clinical testing and diagnosis for Lyme disease. Accessed August 29, 2026. https://www.cdc.gov/lyme/hcp/diagnosis-testing/index.html Back to text
  14. Mead P, Petersen J, Hinckley A. Updated CDC recommendation for serologic diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep. 2019;68(32):703. doi:10.15585/mmwr.mm6832a4 Back to text
  15. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995;44(31):590-591. Back to text
  16. Centers for Disease Control and Prevention. About Southern tick-associated rash illness. Accessed August 29, 2026. https://www.cdc.gov/stari/about/index.html Back to text
  17. Centers for Disease Control and Prevention. Clinical guidance for soft tick relapsing fever (STRF). Accessed August 29, 2026. https://www.cdc.gov/relapsing-fever/hcp/soft-tick-relapsing-fever/index.html Back to text
  18. Centers for Disease Control and Prevention. Leptospirosis. In: CDC Yellow Book: Health Information for International Travel. Accessed August 29, 2026. https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/leptospirosis.html Back to text
  19. Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis—United States. MMWR Recomm Rep. 2016;65(RR-2):1-44. doi:10.15585/mmwr.rr6502a1 Back to text
  20. Federal Select Agent Program. Select agents and toxins list. Accessed August 29, 2026. https://www.selectagents.gov/sat/list.htm Back to text
  21. Centers for Disease Control and Prevention. Biological and chemical terrorism: strategic plan for preparedness and response: recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep. 2000;49(RR-4):1-14. Accessed August 29, 2026. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr4904a1.htm Back to text
  22. Anderson A, Bijlmer H, Fournier PE, et al. Diagnosis and management of Q fever—United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep. 2013;62(RR-3):1-30. Accessed August 29, 2026. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6203a1.htm Back to text
  23. Rhodes KA, Schweizer HP. Antibiotic resistance in Burkholderia species. Microbiol Spectr. 2016;4(3):10.1128/microbiolspec.VMBF-0016-2015. doi:10.1128/microbiolspec.VMBF-0016-2015 Accessed September 11, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC5022785/ Modified lipopolysaccharide conferring intrinsic polymyxin resistance and restrictive outer-membrane permeability as the basis of characteristic aminoglycoside and polymyxin resistance. Back to text
  24. Huse H, Bowden R, Uprety P. A clinical case of Burkholderia cepacia complex and changes to CLSI antimicrobial susceptibility testing recommendations. CLSI AST News Update. 2025;11(November). Disk diffusion breakpoints removed in 2024 (M100 34th ed.) and MIC breakpoints in 2025 (M100 35th ed.); routine AST not recommended; if performed, frozen reference broth microdilution only, with the caution that correlation of MIC values with clinical outcome is not known. Accessed September 11, 2026. https://clsi.org/media/kzhkeain/ast_newsletterfall25_web.pdf Back to text

End of Gram-Negative and Fastidious Bloodstream Isolates

Back to top ↑

Saved lessonsReview and reuse

Enlarged figure